How implementing mass spectrometry-based proteomics tools earlier can boost drug discovery success: Get your free eBook
One of the biggest challenges in drug discovery today is to fully understand the mechanism of action of pharmacologically active compounds and therapeutic targets. An effective solution is the use of powerful cellular thermal shift (CETSA®) mass spectrometry (MS)-based proteomics tools to directly measure drug-target binding in a physiological relevant setting, including interactions with the primary target and any off-targets.
In this eBook, we discuss the two main MS-based proteomics methods you can use in your target identification studies, and why choosing the most efficient and reliable tool from the earliest stage is vital for the long-term success of your research.
The eBook explores:
- Where MS-based proteomics tools fit into the modern drug discovery landscape
- The advantages of CETSA MS over more traditional chemoproteomics approaches
- The benefits you can gain from adopting CETSA MS early in target identification studies
- Case studies demonstrating how CETSA MS is helping to advance drug discovery
Simply fill out the form below to receive your copy.